Leon Aarons

8.0k total citations
255 papers, 5.6k citations indexed

About

Leon Aarons is a scholar working on Statistics and Probability, Pharmacology and Pharmacology. According to data from OpenAlex, Leon Aarons has authored 255 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Statistics and Probability, 46 papers in Pharmacology and 45 papers in Pharmacology. Recurrent topics in Leon Aarons's work include Statistical Methods in Clinical Trials (66 papers), Pharmacogenetics and Drug Metabolism (41 papers) and Antibiotics Pharmacokinetics and Efficacy (37 papers). Leon Aarons is often cited by papers focused on Statistical Methods in Clinical Trials (66 papers), Pharmacogenetics and Drug Metabolism (41 papers) and Antibiotics Pharmacokinetics and Efficacy (37 papers). Leon Aarons collaborates with scholars based in United Kingdom, United States and Switzerland. Leon Aarons's co-authors include Kayode Ogungbenro, Malcolm Rowland, Amin Rostami‐Hodjegan, Aleksandra Galetin, Nikolaos Tsamandouras, Gordon Graham, Ivelina Gueorguieva, J. Brian Houston, Aristides Dokoumetzidis and J. A. Simpson and has published in prestigious journals such as Chemical Society Reviews, The Journal of Chemical Physics and Journal of Clinical Oncology.

In The Last Decade

Leon Aarons

252 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leon Aarons United Kingdom	37	1.3k	973	967	932	920	255	5.6k
Lawrence J. Lesko United States	51	2.2k 1.8×	1.4k 1.4×	882 0.9×	745 0.8×	1.4k 1.5×	172	7.3k
Shiew‐Mei Huang United States	47	2.4k 1.9×	1.1k 1.2×	712 0.7×	385 0.4×	1.8k 2.0×	147	5.7k
Masoud Jamei United Kingdom	45	2.1k 1.7×	1.0k 1.0×	901 0.9×	423 0.5×	1.8k 1.9×	133	6.1k
Kamal K. Midha Canada	29	671 0.5×	1.1k 1.1×	894 0.9×	439 0.5×	530 0.6×	75	5.2k
Stefan Willmann Germany	32	1.0k 0.8×	543 0.6×	705 0.7×	294 0.3×	626 0.7×	93	3.8k
Stuart L. Beal United States	30	726 0.6×	703 0.7×	1.4k 1.4×	1.6k 1.7×	895 1.0×	52	6.6k
Avraham Yacobi United States	32	907 0.7×	1.3k 1.3×	1.2k 1.2×	331 0.4×	648 0.7×	128	6.0k
France Mentré France	50	593 0.5×	1.1k 1.2×	1.1k 1.2×	1.7k 1.8×	979 1.1×	291	9.3k
Nicholas H. G. Holford New Zealand	59	1.8k 1.4×	1.5k 1.5×	3.0k 3.1×	999 1.1×	1.2k 1.3×	210	12.9k
Neil Parrott Switzerland	37	1.5k 1.2×	1.0k 1.1×	573 0.6×	271 0.3×	1.3k 1.4×	125	4.5k

Countries citing papers authored by Leon Aarons

Since Specialization

Citations

This map shows the geographic impact of Leon Aarons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Aarons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Aarons more than expected).

Fields of papers citing papers by Leon Aarons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon Aarons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Aarons. The network helps show where Leon Aarons may publish in the future.

Co-authorship network of co-authors of Leon Aarons

This figure shows the co-authorship network connecting the top 25 collaborators of Leon Aarons. A scholar is included among the top collaborators of Leon Aarons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leon Aarons. Leon Aarons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodson, David, Hitesh Mistry, James Yates, et al.. (2024). Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.. European Journal of Pharmaceutical Sciences. 197. 106774–106774. 3 indexed citations

Olivares‐Morales, Andrés, et al.. (2023). Investigation of simplified physiologically‐based pharmacokinetic models in rat and human. CPT Pharmacometrics & Systems Pharmacology. 12(3). 333–345. 5 indexed citations

Hodson, David, Hitesh Mistry, James Yates, et al.. (2023). Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimization in MC38 Syngeneic Tumors via Modelling and Simulation. Journal of Pharmacology and Experimental Therapeutics. 387(1). 44–54. 2 indexed citations

Mistry, Hitesh, et al.. (2016). Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data. Cancer Chemotherapy and Pharmacology. 77(5). 927–938. 8 indexed citations

Tsamandouras, Nikolaos, et al.. (2015). Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data. The AAPS Journal. 18(1). 196–209. 18 indexed citations

Olivares‐Morales, Andrés, Hans Lennernäs, Leon Aarons, & Amin Rostami‐Hodjegan. (2015). Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption. The AAPS Journal. 17(5). 1177–1192. 18 indexed citations

Tsamandouras, Nikolaos, Gemma L. Dickinson, Yingying Guo, et al.. (2014). Identification of the Effect of Multiple Polymorphisms on the Pharmacokinetics of Simvastatin and Simvastatin Acid Using a Population-Modeling Approach. Clinical Pharmacology & Therapeutics. 96(1). 90–100. 60 indexed citations

Ogungbenro, Kayode, et al.. (2014). Model-Based Evaluation of the Impact of Formulation and Food Intake on the Complex Oral Absorption of Mavoglurant in Healthy Subjects. Pharmaceutical Research. 32(5). 1764–1778. 16 indexed citations

Kostewicz, Edmund, Leon Aarons, Martin Bergstrand, et al.. (2013). PBPK models for the prediction of in vivo performance of oral dosage forms. European Journal of Pharmaceutical Sciences. 57. 300–321. 241 indexed citations

10.

Dahl, Svein G., Leon Aarons, Ursula Gundert‐Remy, et al.. (2009). Incorporating Physiological and Biochemical Mechanisms into Pharmacokinetic–Pharmacodynamic Models: A Conceptual Framework*. Basic & Clinical Pharmacology & Toxicology. 106(1). 2–12. 23 indexed citations

11.

Dickinson, Laura, Marta Boffito, D.J. Back, et al.. (2009). Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers. Journal of Antimicrobial Chemotherapy. 63(6). 1233–1243. 28 indexed citations

12.

Graham, Gordon & Leon Aarons. (2006). Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments. Statistics in Medicine. 25(23). 4004–4019. 25 indexed citations

13.

Ogungbenro, Kayode, Gordon Graham, Ivelina Gueorguieva, & Leon Aarons. (2005). The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments. Computer Methods and Programs in Biomedicine. 80(2). 115–125. 27 indexed citations

14.

Aarons, Leon, Claire Baxter, & Suneel Gupta. (2004). Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions. Biopharmaceutics & Drug Disposition. 25(5). 219–225. 4 indexed citations

15.

Gupta, Suneel, et al.. (2002). Pharmacokinetics of controlled‐release verapamil in healthy volunteers and patients with hypertension or angina. Biopharmaceutics & Drug Disposition. 23(1). 17–31. 4 indexed citations

16.

Nestorov, Ivan, Gordon Graham, Stephen B. Duffull, et al.. (2001). Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan. Pharmaceutical Research. 18(8). 1210–1219. 27 indexed citations

17.

Duffull, Stephen B. & Leon Aarons. (2000). Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers. European Journal of Pharmaceutical Sciences. 10(4). 275–284. 23 indexed citations

18.

Simpson, J. A., Ric N. Price, François Nosten, et al.. (1999). Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clinical Pharmacology & Therapeutics. 66(5). 472–484. 75 indexed citations

19.

Aarons, Leon, Malcolm Rowland, L. P. Balant, et al.. (1996). Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. European Journal of Clinical Pharmacology. 49(4). 251–254. 44 indexed citations

20.

Aarons, Leon, Felix Bochner, & Malcolm Rowland. (1977). A chronic dose-ranging kinetic study of salicylate in man [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(3). 456P–457P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact